Supports planning, development, and pilot studies generating preliminary data to demonstrate feasibility for future interventional lupus studies. Funding allows phase 0/1 clinical trials but excludes phase 2/3 trials and animal studies. Research must address FY26 Lupus Research Program focus areas. Applications require lupus consumer advocate involvement and limit PIs to one application per LRP award mechanism.
Open to any type of entity, with no explicit restrictions stated. Applications must include at least one lupus consumer advocate on the research team. A PI may only lead one application per LRP award mechanism for FY26.
